APA (7th ed.) Citation

Goldberg, A., Geppert, T., Schiopu, E., Frech, T., Hsu, V., Simms, R. W., . . . Yoo, S. (2014). Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: A phase 1, multicenter, open label study. Arthritis research & therapy, 16(1), R57. https://doi.org/10.1186/ar4492

Chicago Style (17th ed.) Citation

Goldberg, Avram, et al. "Dose-escalation of Human Anti-interferon-α Receptor Monoclonal Antibody MEDI-546 in Subjects with Systemic Sclerosis: A Phase 1, Multicenter, Open Label Study." Arthritis Research & Therapy 16, no. 1 (2014): R57. https://doi.org/10.1186/ar4492.

MLA (9th ed.) Citation

Goldberg, Avram, et al. "Dose-escalation of Human Anti-interferon-α Receptor Monoclonal Antibody MEDI-546 in Subjects with Systemic Sclerosis: A Phase 1, Multicenter, Open Label Study." Arthritis Research & Therapy, vol. 16, no. 1, 2014, p. R57, https://doi.org/10.1186/ar4492.